During the past decade, Kameda Medical Center conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 6 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 4 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kameda Medical Center" #1 sponsor was "Celgene" with 12 trials, followed by "Amgen" with 2 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Janssen Pharmaceutical K.K." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kameda Medical Center" #1 collaborator was "Boehringer Ingelheim" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kameda Medical Center" are "Multiple Myeloma" (7 trials), "Myelodysplastic Syndromes" (3 trials), "Anemia" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials) and "Primary Myelofibrosis" (2 trials). Many other conditions were trialed in "Kameda Medical Center" in a lesser frequency.

Most popular intervention types in "Kameda Medical Center" are "Drug" (23 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (8 trials), "Daratumumab" (5 trials), "Lenalidomide" (5 trials), "Bortezomib" (4 trials) and "Carfilzomib" (4 trials). Other intervention names were less common.

The vast majority of trials in "Kameda Medical Center" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Kameda Medical Center". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Kameda Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kameda Medical Center, 4 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".